NCT05079126View on ClinicalTrials.gov

Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 2, 2021

Primary Completion Date

May 25, 2022

Study Completion Date

May 27, 2022

Conditions
Interstitial Lung Disease
Interventions
DRUG

Trans Sodium Crocetinate

Single IV Bolus

DRUG

Placebo

Single IV Bolus

Trial Locations (1)

85032

Pulmonary Associates, P.A., Phoenix

Sponsors
All Listed Sponsors
lead

Diffusion Pharmaceuticals Inc

INDUSTRY